Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules

Jie Ding, Xiang Li, Shengyan Liu, Yinjie Gao, Guoyang Zheng, Marcus Hacker, Yushi Zhang, Anli Tong and Li Huo
Journal of Nuclear Medicine January 2024, 65 (1) 117-124; DOI: https://doi.org/10.2967/jnumed.123.266061
Jie Ding
1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Li
2Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shengyan Liu
3Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yinjie Gao
4Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guoyang Zheng
5Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
2Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yushi Zhang
5Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anli Tong
4Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Huo
1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 1 117-124
DOI 
https://doi.org/10.2967/jnumed.123.266061
PubMed 
38050127

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 24, 2023
  • Revision received October 17, 2023
  • Published online January 2, 2024.

Article Versions

  • previous version (November 30, 2023 - 08:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Jie Ding*,1,
  2. Xiang Li*,2,
  3. Shengyan Liu3,
  4. Yinjie Gao4,
  5. Guoyang Zheng5,
  6. Marcus Hacker2,
  7. Yushi Zhang5,
  8. Anli Tong4 and
  9. Li Huo1
  1. 1Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  2. 2Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria;
  3. 3Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;
  4. 4Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
  5. 5Department of Urological Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
  1. For correspondence or reprints, contact Li Huo (huoli{at}pumch.cn) or Anli Tong (tonganli{at}hotmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 12 Citations
  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Integrated 68Ga-Pentixafor and 68Ga-FAPI-04 PET/MR for Diagnosing Adrenal Aldosterone-Producing Adenoma and Accessory Splenic Nodules
    Jie Ding, Weilun Wang, Xing Chen, Zhiwen You, Jun Zhao
    Clinical Nuclear Medicine 2024 49 12
  • CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response
    Ya Han, Shuo Cao, Jie Liu, Binbin Ding, Shijie Wang, Jihong Pan, Yongpeng Ge, Kai Cheng, Lin Wang, Luna Ge
    EJNMMI Research 2025 15 1
  • Clinical Utility of Dual‐Time 68Ga‐Pentixafor PET/CT in Diagnosing and Subtyping Primary Aldosteronism
    Rui Zuo, Shuang Liu, Xinyi Ren, Wenbo Li, Zhu Xia, Lu Xu, Hua Pang
    Clinical Endocrinology 2025 102 5
  • Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism
    Xiangshuang Zhang, Ying Song, Ying Jing, Jinbo Hu, Hang Shen, Aipin Zhang, Wenwen He, Zhengping Feng, Yi Yang, Hua Pang, Qifu Li, Shumin Yang, Mei Mei, Suxin Luo, Kangla Liao, Yao Zhang, Yunfeng He, Yihong He, Ming Xiao, Bin Peng
    The Journal of Clinical Endocrinology & Metabolism 2024
  • Impact of Cortisol-Cosecretion on Adrenal Venous Sampling Results in Primary Aldosteronism: Study of 225 Cases
    Cristina Lamas, Marta Araujo-Castro, Lukas Ostermair, Erik Petersenn, Paola Parra Ramírez, Ángel Rebollo-Román, Isabel Stuefchen, Denise Bruedgam, Jorge Gabriel Ruiz-Sanchez, Theodora Michalopoulou, Carolina M. Perdomo, Felicia A. Hanzu, Christian Adolf, Martin Reincke
    Biomedicines 2024 12 11
  • 68Ga-pentixafor PET/CT predict the surgical outcome for the primary aldosteronism
    Tingsheng Lin, Jieping Song, Feng Wang, Hongqian Guo
    Clinical and Translational Imaging 2025
  • Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1
    Esther Mena, Liza Lindenberg, Peter Herscovitch, Samira M. Sadowski, Peter L. Choyke
    Seminars in Nuclear Medicine 2025
  • An Unusual Case of Primary Aldosteronism with Negative 68Ga-Pentixafor PET/CT and Positive FDG-PET/CT in a Left Adrenal Adenoma
    Aamir Nazar, Gaurav Malhotra, Sandip Basu
    Indian Journal of Nuclear Medicine 2024 39 6
  • Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis
    Ranbie Tang, Jingguang Pu, Zhanwen Huang
    European Journal of Nuclear Medicine and Molecular Imaging 2025
  • Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?
    Xiang Li, Jie Ding, Stefanie Hahner, Martin Reincke, Marcus Hacker, Constantin Lapa, Li Huo
    Journal of Nuclear Medicine 2024 65 11

Article usage

Article usage: November 2023 to April 2025

AbstractFullPdf
Nov 202355356
Dec 2023772383145
Jan 2024500637199
Feb 202410538369
Mar 202477328101
Apr 20245828484
May 20244416125
Jun 20247051725
Jul 20247934775
Aug 20242845876
Sep 20244340771
Oct 202443405105
Nov 20245138896
Dec 20243440593
Jan 202544409101
Feb 20253643572
Mar 202512244120
Apr 202519163129
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (1)
Journal of Nuclear Medicine
Vol. 65, Issue 1
January 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
Jie Ding, Xiang Li, Shengyan Liu, Yinjie Gao, Guoyang Zheng, Marcus Hacker, Yushi Zhang, Anli Tong, Li Huo
Journal of Nuclear Medicine Jan 2024, 65 (1) 117-124; DOI: 10.2967/jnumed.123.266061

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Value of 68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
Jie Ding, Xiang Li, Shengyan Liu, Yinjie Gao, Guoyang Zheng, Marcus Hacker, Yushi Zhang, Anli Tong, Li Huo
Journal of Nuclear Medicine Jan 2024, 65 (1) 117-124; DOI: 10.2967/jnumed.123.266061
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?
  • Reply: The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
  • The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
  • Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Show more Clinical Investigation

Similar Articles

Keywords

  • C-X-C motif chemokine receptor 4
  • gallium radioisotopes
  • PET
  • primary aldosteronism
SNMMI

© 2025 SNMMI

Powered by HighWire